Stay updated on Pembrolizumab in Advanced Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Sarcomas Clinical Trial page
- Check5 days agoChange DetectedRecruitment status updated to No longer looking for participants, indicating enrollment has ended. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), the Intervention/Treatment header formatting was updated, and the revision label changed to v3.6.0.SummaryDifference0.4%

- Check12 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's template or metadata rather than content changes. No substantive study information appears to be affected.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4. This reflects a page maintenance/version update and does not modify the study content or its presentation.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page’s footer software/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site build update rather than a change to the study record content.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Advanced Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Sarcomas Clinical Trial page.